Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain

NCT02820519 is registered in ClinicalTrials.gov with University of Witten/Herdecke as lead sponsor.

NCT NCT02820519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02820519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
Lead sponsor
University of Witten/Herdecke
Phase
Phase 2
Overall status
Terminated
Start date
June 7, 2016
Completion date
May 4, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain